An International Journal of Otorhinolaryngology Clinics

Register      Login

VOLUME 15 , ISSUE 1 ( January-April, 2023 ) > List of Articles

Original Article

Role of Platelet-rich Plasma in Sensory Neural Hearing Loss

Ruchika, Harendra Kumar Gautam, Surendra Kumar Kanaujia, Mahendra Singh, Ashish Kumar Purwar, AK Arya, Shiroman Singh, Amrita Srivastava

Keywords : Intratympanic injection, Platelet-rich plasma, Sensory neural hearing loss

Citation Information : Ruchika, Gautam HK, Kanaujia SK, Singh M, Purwar AK, Arya A, Singh S, Srivastava A. Role of Platelet-rich Plasma in Sensory Neural Hearing Loss. Int J Otorhinolaryngol Clin 2023; 15 (1):38-41.

DOI: 10.5005/jp-journals-10003-1438

License: CC BY-NC 4.0

Published Online: 16-08-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Introduction: Platelet-rich plasma (PRP) is also known as autologous plasma. Platelets release various growth factors, some of which are recognized to improve nerve growth by contents within the alpha and dense granules. Material and methods: A prospective hospital-based interventional study was carried out at a tertiary care center for a period of 22 months from January 2020 to October 2021. Results: A total of 70 patients were selected according to inclusion criteria and exclusion criteria. In our study, 70 patients with sensory neural hearing loss (SNHL) were selected on the basis of pure-tone audiometry (PTA) and intratympanic PRP injections were given in the affected ear. Post-PRP, patients were followed up till 6 months. Among those patients who had hearing loss for less than six months duration, 85.2% recovered completely while in 14.8% partial recovery was observed. Patients with mild SNHL showed complete recovery in 70.8% and partial recovery in 29.2%. Individuals having moderate SNHL showed complete recovery in 25%, partial in 50%, and no recovery in 25% of cases. Patients in the moderately severe deafness category showed complete recovery in 66.7%, partial in 11.1%, and no recovery in 22.2%. However, in patients with severe SNHL complete recovery was seen only in 42.9%, partial in 14.2%, and in as high as 42.9% no recovery was observed. Only partial improvement was observed in 50% while the remaining 50% showed no recovery. In our study, 41.4% of cases complained of transient dizziness after PRP injection while 61.4% reported pain.

PDF Share
  1. Cruickshanks KJ, Wiley TL, Tweed TS, et al. Prevalence of hearing loss in older adults in Beaver Dam, Wisconsin. The Epidemiology of Hearing Loss Study. Am J Epidemiol 1998;148(9):879–886. DOI: 10.1093/oxfordjournals.aje.a009713.
  2. Marx RE. Platelet-rich plasma (PRP): What is PRP and what is not PRP? Implant Dent 2001;10(4):225–228. DOI: 10.1097/00008505-200110000-00002.
  3. Christgau M, Moder D, Hiller KA, et al. Growth factors and cytokines in autologous platelet concentrate and their correlation to periodontal regeneration outcomes. J Clin Periodontol 2006;33(11):837–845. DOI: 10.1111/j.1600-051X.2006.00991.x.
  4. Choi J, Minn KW, Chang H. The efficacy and safety of platelet-rich plasma and adipose-derived stem cells: An update. Arch Plast Surg 2012;39(6):585–592. DOI: 10.5999/aps.2012.39.6.585.
  5. Ding XG, Li SW, Zheng XM, et al. The effect of platelet-rich plasma on cavernous nerve regeneration in a rat model. Asian J Androl 2009;11(2):215–221. DOI: 10.1038/aja.2008.37.
  6. Bansal D, Varshney S, Malhotra M, et al. Unilateral sensorineural hearing loss: A retrospective study. Indian J Otol 2016;22:262–267. DOI: 10.4103/0971-7749.192174.
  7. Ferri E, Frisina A, Fasson AC, et al. Intratympanic steroid treatment for idiopathic sudden sensorineural hearing loss after failure of intravenous therapy. ISRN Otolaryngol 2012;2012:647271. DOI: 10.5402/2012/647271.
  8. Tyagi BPS, Rout M. Platelet rich plasma (PRP): A revolutionary treatment of sensorineural hearing loss Acta Sci Otolaryngol 2019;1(4):2–5.
  9. Liu YC, Chi FH, Yang TH, et al. Assessment of complications due to intratympanic injections. World J Otorhinolaryngol Head Neck Surg 2016;2(1):13–16.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.